Výsledky vyhledávání - "Johanna Gillhaus"

Safety data from randomized controlled trials: applying models for recurrent events

Autor: Sebastian Kloss, Johanna Gillhaus, Friedhelm Leverkus, Johannes Hengelbrock

Publikováno v: Pharmaceutical statistics. 15(4)

Simple descriptive listings and inference statistics based on 2×2 tables are still the most common way of summarizing and reporting adverse events data from randomized controlled trials, although these methods do not account for differences in obser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940aa3ac00a05a41b19ceb3bb962e246
https://pubmed.ncbi.nlm.nih.gov/27291933

Zobrazit plný text záznamu

Comparison of different prognostic scores versus physician’s subjective prognosis in patients with advanced/metastatic renal cell carcinoma treated with temsirolimus in regular clinical setting: An analysis of the STAR-TOR registry

Autor: Andres Jan Schrader, Michael Woike, Johanna Gillhaus, Martin Boegemann

Publikováno v: Journal of Clinical Oncology. 35:441-441

441 Background: In treatment of metastatic renal cell carcinoma (mRCC) patients several prognostic scores are used: the MSKCC-, IMDC-, and for pts treated with Temsirolimus (TEMS) the Hudes-score. We assessed prognostic value of these scores in TEMS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cc249b85cb36c1eb3216a71bc25b4862
https://doi.org/10.1200/jco.2017.35.6_suppl.441

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání